相似文献
1
Keynote review: allosterism in membrane receptors.
Drug Discov Today. 2006 Mar;11(5-6):191-202. doi: 10.1016/S1359-6446(05)03689-5.
2
Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors.
Curr Drug Targets. 2007 Jan;8(1):169-84. doi: 10.2174/138945007779315614.
3
Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
Pharmacol Rev. 2011 Mar;63(1):59-126. doi: 10.1124/pr.109.002501. Epub 2011 Jan 12.
4
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
Chem Rev. 2016 Jun 8;116(11):6707-41. doi: 10.1021/acs.chemrev.5b00656. Epub 2016 Feb 16.
5
Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.
J Biol Chem. 2014 Jan 17;289(3):1649-61. doi: 10.1074/jbc.M113.507665. Epub 2013 Nov 26.
6
What ligand-gated ion channels can tell us about the allosteric regulation of G protein-coupled receptors.
Prog Mol Biol Transl Sci. 2013;115:291-347. doi: 10.1016/B978-0-12-394587-7.00007-5.
7
Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1.
J Biol Chem. 2004 Aug 20;279(34):35526-34. doi: 10.1074/jbc.M404831200. Epub 2004 Jun 15.
8
Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
ChemMedChem. 2021 Jan 8;16(1):81-93. doi: 10.1002/cmdc.202000444. Epub 2020 Aug 25.
9
Kinetic analysis of fluorescent ligand binding to cell surface receptors: Insights into conformational changes and allosterism in living cells.
Br J Pharmacol. 2024 Nov;181(21):4091-4102. doi: 10.1111/bph.16185. Epub 2023 Jul 19.
10
Profiling of orthosteric and allosteric group-III metabotropic glutamate receptor ligands on various G protein-coupled receptors with Tag-lite assays.
Neuropharmacology. 2018 Sep 15;140:233-245. doi: 10.1016/j.neuropharm.2018.07.032. Epub 2018 Aug 9.
引用本文的文献
1
Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator.
PLoS One. 2015 Mar 23;10(3):e0122012. doi: 10.1371/journal.pone.0122012. eCollection 2015.
2
The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.
Structure. 2013 Dec 3;21(12):2175-85. doi: 10.1016/j.str.2013.09.020. Epub 2013 Nov 7.
3
Allosteric modulation and functional selectivity of G protein-coupled receptors.
Drug Discov Today Technol. 2013 Summer;10(2):e237-43. doi: 10.1016/j.ddtec.2012.08.004.
4
Structure-function of the G protein-coupled receptor superfamily.
Annu Rev Pharmacol Toxicol. 2013;53:531-56. doi: 10.1146/annurev-pharmtox-032112-135923. Epub 2012 Nov 8.
5
The different ways through which specificity works in orthosteric and allosteric drugs.
Curr Pharm Des. 2012;18(9):1311-6. doi: 10.2174/138161212799436377.
6
Diversity and modularity of G protein-coupled receptor structures.
Trends Pharmacol Sci. 2012 Jan;33(1):17-27. doi: 10.1016/j.tips.2011.09.003. Epub 2011 Oct 25.
7
Protection from myocardial ischemia/reperfusion injury by a positive allosteric modulator of the A₃ adenosine receptor.
J Pharmacol Exp Ther. 2012 Jan;340(1):210-7. doi: 10.1124/jpet.111.187559. Epub 2011 Oct 19.
8
The significance of G protein-coupled receptor crystallography for drug discovery.
Pharmacol Rev. 2011 Dec;63(4):901-37. doi: 10.1124/pr.110.003350.
9
Activation and regulation of purinergic P2X receptor channels.
Pharmacol Rev. 2011 Sep;63(3):641-83. doi: 10.1124/pr.110.003129. Epub 2011 Jul 7.
10
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.
Biochem Pharmacol. 2011 Sep 15;82(6):658-68. doi: 10.1016/j.bcp.2011.06.017. Epub 2011 Jun 21.
本文引用的文献
1
On the cooperativity of biological membranes.
Proc Natl Acad Sci U S A. 1967 Feb;57(2):335-41. doi: 10.1073/pnas.57.2.335.
2
Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.
J Med Chem. 2006 Jan 12;49(1):307-17. doi: 10.1021/jm050644n.
3
Chemokines: integrators of pain and inflammation.
Nat Rev Drug Discov. 2005 Oct;4(10):834-44. doi: 10.1038/nrd1852.
4
Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
Mol Pharmacol. 2006 Jan;69(1):236-46. doi: 10.1124/mol.105.017814. Epub 2005 Oct 5.
5
Cinacalcet hydrochloride (Sensipar).
Proc (Bayl Univ Med Cent). 2005 Apr;18(2):181-4. doi: 10.1080/08998280.2005.11928062.
6
Allosteric binding sites on muscarinic acetylcholine receptors.
Mol Pharmacol. 2005 Dec;68(6):1506-9. doi: 10.1124/mol.105.019141. Epub 2005 Sep 23.
7
Targeting the metabotropic glutamate receptor mGluR4 for the treatment of diseases of the central nervous system.
Curr Top Med Chem. 2005;5(9):885-95. doi: 10.2174/1568026054750263.
8
Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2).
Curr Top Med Chem. 2005;5(9):869-84. doi: 10.2174/1568026054750281.
9
Subtype-selective noncompetitive modulators of metabotropic glutamate receptor subtype 1 (mGluR1).
Curr Top Med Chem. 2005;5(9):859-67. doi: 10.2174/1568026054750245.
10
New therapeutic frontiers for metabotropic glutamate receptors.
Curr Top Med Chem. 2005;5(9):847-57. doi: 10.2174/1568026054750254.
Zotero 插件